Randy Berholtz is EVP & CORPORATE DEVELOPMENT at INNOVUS PHARMACEUTICALS, INC. (INNV). They have made 1 open-market trade across 1 company since 2017, most recently 2017-11-22.
CIK 0001520374
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INNV | BUY | 2017-11-22 | 2017-11-27 | $0.10 | $1K | +4.2% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.